By Gaurav Verma, Head – B2C, PharmEasy (API Holdings).
“HPV vaccines now account for nearly 25% of total vaccine sales on PharmEasy, underscoring a clear shift towards preventive healthcare adoption. Women constitute close to 70% of HPV vaccine purchasers. And, the 26–35 age group is emerging as the highest-adopting cohort, reflecting growing awareness around cervical cancer prevention. This Cervical Cancer Awareness Month, our focus remains on driving informed conversations around the appropriate age for HPV vaccination for both boys and girls, improving access to vaccines, and enabling timely, informed health decisions through the PharmEasy platform”, says Gaurav Verma, Head of B2C, PharmEasy (API Holdings).
